Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
My Watchlist
Top Indices
My Portfolio

Novartis Ag ADR (NY: NVS )

96.16 -3.30 (-3.32%)
Official Closing Price Updated: 7:00 PM EDT, Oct 4, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 2,088,955
Open 96.22
Bid (Size) 92.58 (1)
Ask (Size) 105.00 (1)
Prev. Close 99.46
Today's Range 94.93 - 96.41
52wk Range 74.24 - 105.61
Shares Outstanding N/A
Dividend Yield 3.61%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Why Cal-Maine Foods Shares Are Trading Lower By Around 8%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Gainers Gaucho Group Holdings, Inc. (NASDAQ: VINO) jumped 95.2% to $3.7280. Gaucho Group is planning to list two of its retail properties in Argentina, in San Rafael and Cordoba, for sale, priced at $2... 
Via Benzinga
Novartis Shares Decline As Spin Off Sandoz's Market Debut Falls Short of Expected Valuation
Sandoz Group AG (OTC: SDZNY) (OTC: SDZXF) enters a new era as a standalone player in generic and biosimilar medicines. 
Via Benzinga

Performance

YTD
+4.28%
+4.28%
1 Month
-1.97%
-1.97%
3 Month
-2.82%
-2.82%
6 Month
+1.15%
+1.15%
1 Year
+22.92%
+22.92%

More News

Read More
SDZNY Stock: 7 Things to Know as Novartis Spinoff Sandoz Starts Trading Today
Via InvestorPlace
Cancer Drug Maker 3D Medicines Inc. Trading Higher After Company Announces It Will Repurchase Up To 10% Of Outstanding Shares
Via Benzinga
Cal-Maine Foods, A10 Networks And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session
Via Benzinga
Novartis Mulls Divesting Some Assets Of Radiopharma Unit In Strategic Shift
Via Benzinga
Drugmakers Agree To Participate For Medicare Drug Price Negotiation With Biden Administration
Via Benzinga
Novartis' Investigational Therapy Shows Promising Action In Rare Kidney Disease
Via Benzinga
Cardiol Therapeutics 76% YTD Gain Is A Bullish Signal Ahead Of Expected Phase III Trial Announcements ($CRDL)
Via AB Newswire
Topics Death
Exposures Death Product Safety
Fusion Pharmaceuticals Poised For Leadership In Targeted Cancer Therapies: Oppenheimer
Via Benzinga
Allakos' Antibodies For Chronic Skin Conditions, Analyst Sees Over 400% Stock Upside
Via Benzinga
Ionis-Roche Join Forces To Compete In Neurodegenerative Disease Space, Analyst Sees Short-Term Challenges
Via Benzinga
Health Insurer Centene Streamlines - Plans Massive Layoffs To Cut Costs: Report
Via Benzinga
Topics Workforce
Exposures Layoff
Benzinga's Top Ratings Upgrades, Downgrades For September 25, 2023
Via Benzinga
Amazon Invests $4B In ChatGPT Competitor, Hollywood Writers Accept Tentative Deal, ChatGPT Challenges Siri And Alexa With Introduction Of Verbal Responses: Today's Top Stories
Via Benzinga
Novartis Sandoz Prepares For Public Debut With Strong Sales Record And Plans for New Biologic Drugs
Via Benzinga
Are Gene Therapy Stocks The Market's Next Big Winners?
Via MarketBeat
Topics Artificial Intelligence
Exposures Artificial Intelligence
Novartis Precision Cancer Therapy Hits Primary Goal In Rare Type Of Pancreatic Cancer
Via Benzinga
Week In Review: Everest Acquires Novel Autoimmune Therapy In $132 Million Agreement
Via Talk Markets
AI To Revolutionize Clinical Trials And Diagnostics
Via Benzinga
Topics Artificial Intelligence
Exposures Artificial Intelligence
From Years to Months: How AI is Shaping the Landscape of Clinical Trials
Via Benzinga
Topics Artificial Intelligence
Exposures Artificial Intelligence
Preventable Vaccines Market May See a Big Move : AstraZeneca, GlaxoSmithKline, Merck
Via SBWire
Amazon Poaches Microsoft's Product Chief, Google And DoD Team Up For AI-Powered Microscope To Identify Cancer, Rocket Lab's 41st Mission Succumbed To Technical Issues: Today's Top Stories
Via Benzinga
Chinese Drugmaker BeiGene And Novartis Move Out From Second Cancer Drug Pact
Via Benzinga
AMC Stock Alert: Adam Aron Teases New Chocolate, Wine Brands for AMC
Via InvestorPlace
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.